Pharmacokinetic calculation in missing samples [Study As­sess­ment]

posted by drplacebo – 2008-11-10 10:05 (6440 d 03:33 ago) – Posting: # 2645
Views: 5,256

Dear all
In a two way, single-dose bioequivalence study,we have two subjects missing 3-4 samples in the elimination phase for only one period. Hence in this case when we calculate AUCt, there is going to be an under estimation for AUC of product taken during the missed samples period. I would like to know how to proceed further? should we trucate to equal time points in both periods or drop the complete data of two subjects from the analysis?
Kindly let me know if any regulatory agency has defined the same

Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
277 visitors (1 registered, 276 guests [including 22 identified bots]).
Forum time: 14:39 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5